Cargando…
The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells
Around 15% of cancer cases are attributable to infectious agents. Epidemiological studies suggest that an association between leishmaniasis and cancer does exist. Recently, the homologue of PES1 in Leishmania major (LmjPES) was described to be involved in parasite infectivity. Mammalian PES1 protein...
Autores principales: | Larrea, Esther, Fernández-Rubio, Celia, Peña-Guerrero, José, Guruceaga, Elizabeth, Nguewa, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655562/ https://www.ncbi.nlm.nih.gov/pubmed/36361992 http://dx.doi.org/10.3390/ijms232113203 |
Ejemplares similares
-
In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity
por: Algarabel, Miriam, et al.
Publicado: (2021) -
LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome
por: Vacas, Andrés, et al.
Publicado: (2020) -
Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis
por: Peña-Guerrero, José, et al.
Publicado: (2021) -
The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major May Be Involved in the Resistance to Drugs such as Paromomycin
por: Vacas, Andrés, et al.
Publicado: (2019) -
The BRCT domain of mammalian Pes1 is crucial for nucleolar localization and rRNA processing
por: Hölzel, Michael, et al.
Publicado: (2007)